Education
About Us
Working with TipRanks
Follow Us
Oxford BioDynamics PLC (GB:OBD)
LSE:OBD
OBD Stock Chart & Stats
Day’s Range― - ―
52-Week Range0.23p - 7.40p
Previous CloseN/A
Volume22.58K
Average Volume (3M)50.91M
Market Cap
£9.30M
Enterprise Value4.92M
Total Cash (Recent Filing)£1.19M
Total Debt (Recent Filing)£6.00M
Price to Earnings (P/E)―
Beta-1.63
Next Earnings
Jan 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,957,577,600
10 Day Avg. Volume22,176,384
30 Day Avg. Volume50,906,846
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£0.50Price Target Upside4.17% Upside
Rating ConsensusHold
Number of Analyst Covering0
Oxford BioDynamics News
OBD FAQ
What was Oxford BioDynamics PLC’s price range in the past 12 months?
Oxford BioDynamics PLC lowest share price was 0.23p and its highest was 7.40p in the past 12 months.
What is Oxford BioDynamics PLC’s market cap?
Oxford BioDynamics PLC’s market cap is £9.30M.
When is Oxford BioDynamics PLC’s upcoming earnings report date?
Oxford BioDynamics PLC’s upcoming earnings report date is Jan 27, 2026 which is in 151 days.
How were Oxford BioDynamics PLC’s earnings last quarter?
Oxford BioDynamics PLC released its earnings results on Jun 30, 2025. The company reported -0.007p earnings per share for the quarter, missing the consensus estimate of N/A by -0.007p.
Is Oxford BioDynamics PLC overvalued?
According to Wall Street analysts Oxford BioDynamics PLC’s price is currently Undervalued.
Does Oxford BioDynamics PLC pay dividends?
Oxford BioDynamics PLC does not currently pay dividends.
What is Oxford BioDynamics PLC’s EPS estimate?
Oxford BioDynamics PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oxford BioDynamics PLC have?
Oxford BioDynamics PLC has 1,957,577,600 shares outstanding.
What happened to Oxford BioDynamics PLC’s price movement after its last earnings report?
Oxford BioDynamics PLC reported an EPS of -0.007p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -13.514%.
Which hedge fund is a major shareholder of Oxford BioDynamics PLC?
Currently, no hedge funds are holding shares in GB:OBD
Company Description
Oxford BioDynamics PLC
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures for use in medical testing kits, disease prediction, diagnosis, and treatment. Its products include EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a validated prognostic test for predicting response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling and biomarker discovery. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.
Technical Analysis
IXICO plc
―
HemoGenyx Pharmaceuticals Plc
―
Fusion Antibodies Plc
―
Arecor Therapeutics PLC
―
Aptamer Group Plc
―
Ownership Overview
14.93% Insiders
―
Mutual Funds
― Other Institutional Investors
85.07% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---